HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pardeep S Jhund Selected Research

Neprilysin (Neutral Endopeptidase)

1/2022Angiotensin-neprilysin inhibition and renal outcomes across the spectrum of ejection fraction in heart failure.
12/2021Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON-HF.
1/2021Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction.
1/2021Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.
1/2021Incidence and Outcomes of Pneumonia in Patients With Heart Failure.
1/2021Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodelling.
1/2021Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
11/2020Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials.
10/2020Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan: The DAPA-HF Trial.
1/2020Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection Fraction.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pardeep S Jhund Research Topics

Disease

147Heart Failure
08/2022 - 08/2005
16Stroke (Strokes)
11/2021 - 12/2010
15Type 2 Diabetes Mellitus (MODY)
10/2022 - 11/2011
14Myocardial Infarction
01/2022 - 11/2011
14Atrial Fibrillation
01/2022 - 12/2012
13Cardiomyopathies (Cardiomyopathy)
01/2022 - 06/2014
10Diabetes Mellitus
01/2021 - 11/2011
8Chronic Renal Insufficiency
10/2022 - 06/2010
8Sudden Death
01/2022 - 01/2017
7Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 01/2018
6Chronic Obstructive Pulmonary Disease (COPD)
01/2022 - 10/2016
6Left Ventricular Dysfunction
01/2021 - 11/2015
6Hypotension (Low Blood Pressure)
01/2020 - 10/2015
5Hypertension (High Blood Pressure)
01/2022 - 12/2012
4Chronic Kidney Failure (Chronic Renal Failure)
01/2022 - 09/2015
4Cardiac Arrhythmias (Arrythmia)
01/2022 - 11/2020
3Respiratory Sounds (Crackle)
01/2022 - 01/2020
3Frailty
01/2022 - 06/2014
3Neoplasms (Cancer)
08/2021 - 10/2016
3Prediabetic State (Prediabetes)
01/2021 - 01/2020
3Coronary Artery Disease (Coronary Atherosclerosis)
11/2016 - 07/2015
2Heart Arrest (Cardiac Arrest)
01/2022 - 01/2021
2Shock
01/2022 - 06/2014
2Heart Diseases (Heart Disease)
01/2022 - 10/2019
2Bundle-Branch Block (Fascicular Block)
08/2021 - 01/2016
2Cardiac Sudden Death (Sudden Cardiac Arrest)
08/2019 - 01/2018
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2019 - 06/2014
2Systolic Heart Failure
01/2018 - 06/2014
2Angina Pectoris
12/2014 - 12/2012
1COVID-19
01/2022
1Gout
01/2022
1Hyponatremia
01/2022
1Tachycardia (Tachyarrhythmias)
12/2021
1Renal Insufficiency (Renal Failure)
11/2021
1Atherosclerosis
10/2021
1Fibrosis (Cirrhosis)
10/2021
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
08/2021

Drug/Important Bio-Agent (IBA)

37dapagliflozinIBA
08/2022 - 11/2019
32sacubitril and valsartan sodium hydrate drug combinationIBA
01/2022 - 06/2014
24Brain Natriuretic Peptide (Natrecor)FDA Link
01/2022 - 02/2014
21Neprilysin (Neutral Endopeptidase)IBA
01/2022 - 06/2014
16pro-brain natriuretic peptide (1-76)IBA
01/2022 - 02/2014
15Angiotensin Receptors (Angiotensin II Receptor)IBA
12/2021 - 06/2014
14IrbesartanFDA LinkGeneric
08/2021 - 12/2012
13Mineralocorticoid Receptor AntagonistsIBA
01/2022 - 01/2017
13Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2022 - 08/2005
13candesartanIBA
08/2021 - 12/2012
11EnalaprilFDA LinkGeneric
01/2022 - 01/2017
11Valsartan (Vals)FDA Link
01/2022 - 06/2014
11Angiotensin Receptor AntagonistsIBA
01/2022 - 02/2014
11Glucose (Dextrose)FDA LinkGeneric
10/2021 - 12/2017
10DiureticsIBA
01/2022 - 01/2016
8SodiumIBA
01/2022 - 01/2019
8paragonIBA
12/2021 - 01/2020
8aliskirenFDA Link
08/2021 - 09/2015
7Rosuvastatin Calcium (Crestor)FDA Link
12/2015 - 02/2014
6CreatinineIBA
01/2022 - 09/2015
6Natriuretic PeptidesIBA
01/2022 - 10/2019
6Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2022 - 08/2005
6Sodium-Glucose Transport ProteinsIBA
11/2021 - 11/2019
6Sodium-Glucose Transporter 2 InhibitorsIBA
11/2020 - 11/2019
5AngiotensinsIBA
01/2022 - 01/2016
5Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2016
5Pharmaceutical PreparationsIBA
01/2022 - 01/2017
5Insulin (Novolin)FDA Link
01/2022 - 04/2015
4SymportersIBA
10/2021 - 01/2020
4empagliflozinIBA
01/2021 - 01/2020
3Troponin T (Troponin T1)IBA
01/2022 - 11/2014
3IronIBA
12/2021 - 01/2021
3Hemoglobins (Hemoglobin)IBA
11/2021 - 01/2016
3Antihypertensive Agents (Antihypertensives)IBA
10/2021 - 01/2021
3Peptides (Polypeptides)IBA
01/2021 - 01/2017
3Spironolactone (Aldactone)FDA LinkGeneric
12/2020 - 11/2016
3Eplerenone (Inspra)FDA LinkGeneric
01/2020 - 11/2015
3Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2020 - 11/2011
3Digoxin (Digitek)FDA LinkGeneric
01/2019 - 04/2016
2Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2022 - 01/2021
2Uric Acid (Urate)IBA
01/2022 - 01/2018
2TroponinIBA
01/2022 - 11/2014
2Serum AlbuminIBA
11/2021 - 08/2021
2CholesterolIBA
01/2021 - 01/2019
2SugarsIBA
01/2021 - 01/2021
2CanagliflozinIBA
11/2020 - 01/2020
2Trinitrotoluene (TNT)IBA
01/2019 - 11/2014
2AnticoagulantsIBA
11/2017 - 01/2016
1finerenoneIBA
10/2022
1antineoplaston A10 (A 10)IBA
08/2022
1C-Reactive ProteinIBA
11/2021
1GadoliniumIBA
10/2021

Therapy/Procedure

45Therapeutics
01/2022 - 06/2014
6Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
01/2022 - 02/2014
3Drug Therapy (Chemotherapy)
01/2022 - 01/2016
3Renal Dialysis (Hemodialysis)
11/2021 - 09/2015
2Defibrillators (Defibrillator)
01/2022 - 06/2014
2Cardiac Resynchronization Therapy
01/2022 - 01/2021
2Catheter Ablation
12/2021 - 01/2018
2Home Nursing (Nursing, Home)
01/2021 - 01/2018
2Patient Readmission
01/2018 - 01/2015
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2016 - 11/2015
2Length of Stay
10/2016 - 04/2014